Shell Asset Management CO Roivant Sciences Ltd. Transaction History
Shell Asset Management CO
- $2.29 Billion
- Q4 2024
A detailed history of Shell Asset Management CO transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Shell Asset Management CO holds 16,890 shares of ROIV stock, worth $175,318. This represents 0.01% of its overall portfolio holdings.
Number of Shares
16,890
Previous 16,890
-0.0%
Holding current value
$175,318
Previous $195,000
2.56%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding ROIV
# of Institutions
332Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$683 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$644 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$496 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$458 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$367 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.31B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...